U.S. Markets open in 7 hrs 40 mins

Endo International plc (ENDP)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
13.12+0.23 (+1.78%)
At close: 4:00PM EDT
People also watch
VRXMYLPRGOALXNHZNP
  • This issue has the strangest pricing action. I guess it's called random.
  • ENDP was at the global healthcare conference from USB today.
    They talked a lot about the future and they see it very bright.
    I see the feature bright as well, this is a long term investment. I'm in at 11.20.
    I think it should get around $30 in a couple of years based on their sales growth from their new porfolio.
  • Mizuho Securities raised its price target on Endo International plc (NASDAQ: ENDP) to $19.00 (from $18.00) while maintaining a Buy rating.

    Analyst Irina Koffler cites the company's positioning for consolidation within the generics space as the company possesses a growing portfolio of sterile injectables.
  • Nice run so far today. Need to get back to the $14 level and take off from there!
  • "question for old timers. "
    Please define "old timers."
    nt
  • question for old timers.
    What put a plug on this stock (not company) growth? I see a big short interest, fundamentals are all in place, earnings are good, PE is low. On a current bullish market it should be 30-35 stock. Any idea?
  • I'm now reasonably convinced that this is a long-term waiting game. It will extend well into 2018. Those who are patient will get a double or maybe even a triple. That's pretty good reward for waiting. Impatience is your enemy.
  • Gabelli & Co. 5/10/17:
    " We continue to recommend Endo and believe that the generics business is an attractive asset. Using a 10x EBITDA multiple, the generics business is worth the entire enterprise value of Endo (including accrued mesh liability costs), giving investors a $1 billion plus revenue branded drug business for free".
  • From 14 to...almost...11s??
  • Refreshing to see a one point jump in a day. It will go higher, but there is considerable short interest so the climb has been gradual. A good long term buy with exceptional multiples into 2018.
  • Both ENDP and VRX are great plays, albeit both are still a little in the rough. Careful accumulation and discipline to hold long term will more than double your investment. Don't expect a quick turnover. You will be frustrated.
  • ENDP. Consistently good ERs and always trashed a few weeks later. Someday this pattern will be broken and the patient longs will get their reward.
  • Strong finish. Need to see this break out and not give up the gains.
  • Is thing cursed or what ?
  • forward PE is below 4. Do you still believe that so humiliating trading will be continued forever? This stock must be in 40-45 at least and it means it will be. The only question is how. I'll tell you how: with big leaps in vicinity of each earnings. From 10 to 13 (30% in a blink of an eye). The next move can be even bigger, say from 13 to 18 i.e. those who are not inside have zero chance to make money.
  • Another give-back at the eod.
  • Does this stock not have its own mind, earnings and outlook. Why sniff and follow Valiant.
  • Would be encouraging to close in the 13s again.
  • Crossed 14! $50 by eoy.
  • ENDP is not more than $5